NasdaqCM - Nasdaq Real Time Price USD

Notable Labs, Ltd. (NTBL)

Compare
0.4000 +0.0099 (+2.54%)
At close: October 11 at 4:00 PM EDT
0.2500 -0.14 (-35.91%)
Pre-Market: 9:12 AM EDT
Loading Chart for NTBL
DELL
  • Previous Close 0.3901
  • Open 0.3800
  • Bid --
  • Ask --
  • Day's Range 0.4000 - 0.4000
  • 52 Week Range 0.3800 - 5.2700
  • Volume 17,032
  • Avg. Volume 77,678
  • Market Cap (intraday) 3.864M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -1.0900
  • Earnings Date Nov 12, 2024 - Nov 18, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 9.00

Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and enables fast-track therapeutic development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor to induce cell cycle arrest and apoptosis in various cancer cells; and Fosciclopirox, a pro-drug of ciclopirox for acute myeloid leukemia. Notable Labs, Ltd. was incorporated in 2014 and is headquartered in Foster City, California. On October 13, 2024, Notable Labs, Ltd. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

www.notablelabs.com

16

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NTBL

View More

Performance Overview: NTBL

Trailing total returns as of 10/14/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NTBL
78.84%
S&P 500
22.85%

1-Year Return

NTBL
93.32%
S&P 500
35.40%

3-Year Return

NTBL
99.47%
S&P 500
34.28%

5-Year Return

NTBL
99.11%
S&P 500
97.28%

Compare To: NTBL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NTBL

View More

Valuation Measures

Annual
As of 10/14/2024
  • Market Cap

    3.86M

  • Enterprise Value

    1.57M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    12.34

  • Price/Book (mrq)

    0.54

  • Enterprise Value/Revenue

    5.01

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -106.09%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    313k

  • Net Income Avi to Common (ttm)

    -10.54M

  • Diluted EPS (ttm)

    -1.0900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.09M

  • Total Debt/Equity (mrq)

    24.98%

  • Levered Free Cash Flow (ttm)

    -11.46M

Research Analysis: NTBL

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 2k
Earnings -5.22M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

9.00
9.00 Average
0.4000 Current
9.00 High
 

Company Insights: NTBL

People Also Watch